Outcomes of sunitinib therapy in patients (pts) with metastatic renal cell carcinoma (mRCC) with poor risk features.
Romualdo Barroso-Sousa
No relevant relationships to disclose
Rodrigo Ramella Munhoz
No relevant relationships to disclose
Leonardo Gomes Fonseca
No relevant relationships to disclose
Angelo Bezerra de Sousa Fede
No relevant relationships to disclose
Rudinei Diogo Marques Linck
No relevant relationships to disclose
Camila Motta Venchiarutti Moniz
No relevant relationships to disclose
Milena Perez Mak
No relevant relationships to disclose
Ciro Eduardo Souza
Consultant or Advisory Role - Pfizer
Expert Testimony - Pfizer
Paulo M. Hoff
No relevant relationships to disclose
Carlos Dzik
No relevant relationships to disclose